Oct. 24 at 8:49 AM
$INTS qutoes“Treatments such as chemotherapy and immunotherapy impact a patient’s entire body, with toxic side effects. Intensity’s technology takes a different approach, with our drug being injected directly into the patients’ tumors; healthy cells throughout the body are spared. As the cancer cells die, the immune system begins to recognize the cancer. Essentially, we debulk the live cancer and convert a person’s tumor into their own personal anticancer vaccine, inducing a systemic adaptive immune response.
Our proprietary chemistry enables the active agents to be soluble in both fat and water simultaneously. Almost all drugs are given intravenously or orally to fight metastatic disease systemically. Our local therapy kills tumors and stimulates the immune system to attack the tumors that we do not inject. After intratumoral injection with INT230-6, the cytotoxic agents disperse throughout the tumor and diffuse into the cancer cells.
